Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
February 22, 2026
An oBservational retrospective Analysis of treatment patternS and Effectiveness of standard of CAre for Multiple Myeloma Patients Exposed to Lenalidomide and a Proteasome Inhibitor: BasecaMMp Study
Klaus Martin Kortüm, James Farrell, Olivia Ashman, et al.
Gastrointestinal Endoscopy
|
December 16, 2023
Clinical predictive value of renalase in post-ERCP pancreatitis
Thiruvengadam Muniraj, Gary Desir, Fred S Gorelick, et al.
Molecular and Clinical Oncology
|
October 4, 2014
Predominance of ERG-negative high-grade prostate cancers in African American men
James Farrell, Denise Young, Yongmei Chen, et al.
Diagnostic Cytopathology
|
March 19, 2014
Postbrushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: the Papanicolaou Society of Cytopathology guidelines
Daniel Kurtycz, Z Laura Tabatabai, Claire Michaels, et al.
Cytojournal
|
September 6, 2014
Post-brushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: The Papanicolaou Society of Cytopathology Guidelines
Daniel F I Kurtycz, Andrew Field, Laura Tabatabai, et al.
Radiology
|
October 2, 2004
Autoimmune pancreatitis: imaging features
Dushyant V Sahani, Sanjeeva P Kalva, James Farrell, et al.
BMC Cancer
|
August 8, 2025
Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data
Martin Kortüm, Sebastian Theurich, James Farrell, et al.
Patient Preference and Adherence
|
April 22, 2025
Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies
Sikander Ailawadhi, Yelak Biru, Solène Clavreul, et al.
Leukemia & Lymphoma
|
July 27, 2023
An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma
Paula Rodríguez Otero, Kevin Towle, Shannon Cope, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 4, 2012
Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia
Mitsuro Kanda, Yoshihiko Sadakari, Michael Borges, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Clinical Lymphoma, Myeloma & Leukemia
|
February 22, 2026
An oBservational retrospective Analysis of treatment patternS and Effectiveness of standard of CAre for Multiple Myeloma Patients Exposed to Lenalidomide and a Proteasome Inhibitor: BasecaMMp Study
Klaus Martin Kortüm, James Farrell, Olivia Ashman, et al.
Gastrointestinal Endoscopy
|
December 16, 2023
Clinical predictive value of renalase in post-ERCP pancreatitis
Thiruvengadam Muniraj, Gary Desir, Fred S Gorelick, et al.
Molecular and Clinical Oncology
|
October 4, 2014
Predominance of ERG-negative high-grade prostate cancers in African American men
James Farrell, Denise Young, Yongmei Chen, et al.
Diagnostic Cytopathology
|
March 19, 2014
Postbrushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: the Papanicolaou Society of Cytopathology guidelines
Daniel Kurtycz, Z Laura Tabatabai, Claire Michaels, et al.
Cytojournal
|
September 6, 2014
Post-brushing and fine-needle aspiration biopsy follow-up and treatment options for patients with pancreatobiliary lesions: The Papanicolaou Society of Cytopathology Guidelines
Daniel F I Kurtycz, Andrew Field, Laura Tabatabai, et al.
Radiology
|
October 2, 2004
Autoimmune pancreatitis: imaging features
Dushyant V Sahani, Sanjeeva P Kalva, James Farrell, et al.
BMC Cancer
|
August 8, 2025
Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data
Martin Kortüm, Sebastian Theurich, James Farrell, et al.
Patient Preference and Adherence
|
April 22, 2025
Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies
Sikander Ailawadhi, Yelak Biru, Solène Clavreul, et al.
Leukemia & Lymphoma
|
July 27, 2023
An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma
Paula Rodríguez Otero, Kevin Towle, Shannon Cope, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 4, 2012
Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia
Mitsuro Kanda, Yoshihiko Sadakari, Michael Borges, et al.
Page
of 9